We investigated the cytoprotective effects of lithium, the mood-stabilizer, on thapsigargin-induced stress on the endoplasmic reticulum (ER) in rat PC12 cells. Protracted lithium pretreatment of PC12 cells elicited cytoprotection against thapsigargin-induced cytotoxicity. Lithium protection was concurrent with inhibition of thapsigargin-induced intracellular calcium increase and with elevated expression of the molecular chaperone GRP78. Moreover, lithium pretreatment upregulated the antiapoptotic protein Bcl-2, and blocked Bcl-2 downregulation elicited by thapsigargin. Prior to the induction of GRP78, lithium treatment alone increased the expression of c-Fos whose induction by ER stress is necessary for GRP78 induction. Curcumin, an inhibitor of transcription factor AP-1, blocked lithium cytoprotection against thapsigargin cytotoxicity. Thus, the induction of GRP78 and Bcl-2, and activation of AP-1 likely contribute to lithium-induced protection against cytotoxicity resulting from ER stress. Additionally, thapsigargin-induced cytotoxicity was suppressed by pretreatment with another mood-stabilizer, valproate, indicating that cytoprotection against ER stress is a common action of mood-stabilizing drugs.
INTRODUCTION
The endoplasmic reticulum (ER) is the primary site for protein synthesis, folding and trafficking. It also acts as an intracellular calcium repository and regulates calcium signaling. The ER is highly sensitive to alterations in calcium homeostasis and perturbations of its intralumenal environment. Thus, calcium ionophores and agents such as thapsigargin an ER Ca 2 þ -ATPase inhibitor, that lead to the depletion of calcium levels from the ER lumen, inhibitors of glycosylation such as tunicamycin, oxidative stress, impairment of protein transport from the ER to the Golgi, and/or accumulation of misfolded protein inchaperone glucose-regulated protein (GRP) 78 and calreticulin. 5 In addition, some Bcl-2 family members have been found associated with the ER and have been implicated in the regulation of calcium homeostasis. 6, 7 Therefore, proper function of the ER is essential for cell survival, while ER stress results in apoptosis. Impaired ER function has also been linked to the neuropathology of a variety of neurodegenerative diseases that involve neuronal apoptosis, such as cerebral ischemia and Alzheimer's disease (reviewed in Mattson et al, 8 Sherman and Goldberg, 9 and Paschen 10 ). The mood-stabilizing drugs, particularly lithium, have emerged as neuroprotective agents effective in protecting against apoptosis-dependent cell death both in vitro and in vivo. The in vitro studies have shown that lithium is neuroprotective in multiple cell types including rodent cerebellar granule cells, cortical neurons, hippocampal neurons, 11, 12 PC12 cells 13 and human neuroblastoma cells.
14 Furthermore, in vitro lithium treatment has successfully provided neuroprotection against a variety of insults including glutamate excitotoxicity, 11, 12, 15 anticonvulsants, 16 ouabain, 17, 18 potassium-deprivation, 19 b-amyloid peptide 13, 20 and b-bungarotoxin, 21 among others. Lithium has also been shown to be neuroprotective in several animal models of diseases and insults. These include permanent cerebral ischemia, 22 transient cerebral ischemia, 23, 24 quinolinic acid-induced striatal injury, 25, 26 excitotoxic lesions of the cholinergic system 27 and kainic acid-induced brain damage. 28 Lithium-induced neuroprotection is mediated through multiple mechanisms and actions. Induction of brainderived neurotrophic factor and activation of its receptor, TrkB, is an essential step in lithium neuroprotection against glutamate-induced excitotoxicity in cortical neurons. 29 Downstream events caused by TrkB stimulation such as activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase (MAPK) pathways are also correlated with lithium's protective effects in cerebellar granule cells and other cell types. [30] [31] [32] In addition, lithium reduces proapoptotic function by directly and indirectly inhibiting glycogen synthase kinase-3 (GSK-3) activity 30, [33] [34] [35] and indirectly inhibiting N-methyl-D-aspartate (NMDA)-receptor-mediated calcium influx presumably through suppression of Src-mediated NMDA receptor tyrosine phosphorylation. 11, 12, 36 It has been recently reported that GSK-3b has a central role in regulating ER stressinduced caspase activation in neuroblastoma cells. 37 The present study was undertaken to (1) investigate whether lithium has neuroprotective effects against cytotoxicity of PC12 cells induced by thapsigargin, a specific and potent inhibitor of Ca 2 þ -ATPase in the ER, 38 (2) to determine if lithium cytoprotection is correlated with the induction of the chaperone protein GRP78, and the antiapoptotic protein Bcl-2, (3) to explore the cytoprotective role of GRP78 and the potential role of activator protein-1 (AP-1) in the lithium cytoprotection and (4) to determine whether the cytoprotective effects can be extended to valproate (VPA), another mood-stabilizing drug used to treat bipolar disorder.
RESULTS
We investigated the cytoprotective effect of lithium treatment against thapsigargin-induced cytotoxicity in rat PC12 pheochromocytoma cells. Cell viability was quantified using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) or lactate dehydrogenase (LDH) assays. Exposure of PC12 cells to thapsigargin for 24 h induced a concentration-dependent loss of MTT reducing activity. Thapsigargin-induced cytotoxicity in PC12 cells occurred at concentrations higher than 30 nM with more than 60% of cell death at 300 nM ( Figure 1a Po0.01 compared with untreated control. Effects of lithium on thapsigargininduced cytotoxicity. PC12 cells were pretreated with 2 mM lithium chloride for 7 days, and then treated with thapsigargin at different concentrations for 24 h. Cell viability was measured by MTT (a) or LDH release (b). *Po0.05, **Po0.01 compared with the corresponding vehicle control. LDH release from untreated cells and cells lysed with 0.9% Triton X-100 were regarded as 0% LDH release and 100% LDH release, respectively. (c) Lithium dose-dependently protects PC12 cells from thapsigargin-induced cytotoxicity. Cells were pretreated with lithium chloride at seven different concentrations for 7 days and cell viability was measured by MTT assay after treatment with 100 nM thapsigargin for 24 h. Data shown are means7SEM of three independent experiments and are expressed as % of untreated control as indicated by the dotted line. *Po0.05, **Po0.01 compared with untreated control. with 2 mM lithium chloride for 7 days significantly suppressed thapsigargin's ability to reduce MTT and release LDH from cells ( Figure 1a and b) , indicating that lithium elicited cytoprotection against thapsigargin-induced cytotoxicity. Treatment with lithium chloride alone slightly increased the MTT reducing activity of untreated cells (Figure 1a ), confirming our previous report. 13 Significant cytoprotection of lithium against thapsigargin-induced cytotoxicity was observed at concentrations between 0.5 and 2.5 mM (Figure 1c) . The optimal dose of lithium for cytoprotection was approximately 2 mM.
Treatment of PC12 cells with 100 nM thapsigargin caused the release of calcium into the cytoplasm from ER stores (Figure 2a) . Pretreatment of these cultures with 2 mM lithium chloride for 7 days significantly reduced the peak of intracellular calcium stimulated by subsequent treatment with thapsigargin (a change of 463 nM Ca 2 þ after lithium treatment vs 644 nM in untreated controls after subtraction of basal values) (Figure 2b ).
Recent reports have demonstrated that 78 kDa glucoseregulated protein (GRP78), a molecular chaperone of the heat shock protein 70 family, which assists with the refolding of misfolded proteins in the endoplasmic reticulum, has neuroprotective effects. 39, 40 The mRNA of GRP78 is induced by thapsigargin and various insults that cause programmed cell death. 41, 42 To investigate the effects of lithium on GRP78 expression, PC12 cells were pretreated with 2 mM lithium chloride for 7 days and then treated with 50 nM thapsigargin for 24 h. The levels of GRP78 protein in PC12 cells increased not only after thapsigargin treatment, but also with lithium pretreatment (Figure 3a) . Time course experiments showed that the effects of lithium on GRP78 levels were time-dependent with a minimal requirement of 5-day pretreatment to elicit a significant increase ( Figure  3b ). Pretreatment with lithium for 5 days also caused a significant reduction of thapsigargin-induced cell death (Figure 3c) . Thus, the cytoprotective effects of lithium chloride temporally correlated with the induction of GRP78.
c-Fos, a member of the b-Zip family of transcription factors, is involved in the transcription of GRP78, and a dominant-negative inhibitor of c-Fos, A-Fos, blocks thapsigargin-induced GRP78 expression. 42 Lithium has been shown to increase c-Fos mRNA in PC12 cells 43 and cerebellar granule cells. 44 Therefore, we investigated whether c-Fos is induced during the course of lithium pretreatment in our conditions. PC12 cells were harvested after treatment with 2 mM lithium chloride for 1 to 7 days, and Western blotting analysis of c-Fos protein was performed. c-Fos protein was induced 1 and 3 days after lithium treatment, preceding the induction of GRP78 (Figure 4a ). Moreover, the levels of c-Fos mRNA were rapidly increased after lithium treatment ( Figure 4b ).
It is well established that c-Fos protein is a component of the transcription factor complex involved in AP-1 binding activity. To investigate whether c-Fos-dependent AP-1 binding is involved in the cytoprotective action of lithium, PC12 cells were pretreated for 6 days with 2 mM lithium chloride in the absence or presence of 10 mM curcumin, an inhibitor of AP-1 binding activity. 45 Cell viability was measured by MTT assay after treatment with thapsigargin for 24 h. Curcumin at 10 mM did not affect thapsigargin-induced cytotoxicity nor cell viability of untreated cultures ( Figure  5a ). However, curcumin almost completely blocked lithium cytoprotection against thapsigargin cytotoxicity. Gel shift assays confirmed that curcumin suppressed AP-1 binding activity ( Figure 5b ).
It has been suggested that one of the antiapoptotic actions of Bcl-2 is to antagonize ER stress-induced cell damage. Lithium, ER stress, and neuroprotection
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Therefore, we investigated the effects of thapsigargin and lithium on levels of Bcl-2. Thapsigargin (100 nM) pretreatment for 12 h reduced Bcl-2 levels by more than 50% ( Figure  6 ), although the cell morphology was not significantly affected under these conditions. In contrast, Bcl-2 protein levels were significantly increased by lithium treatment for 7 days, confirming our previous results in PC12 cells and The effects of 7 day curcumin (10 lM) treatment on basal AP-1 was also determined by gel shift assay as described in the Materials and Methods. *Po0.05.
Lithium, ER stress, and neuroprotection T Hiroi et al cerebellar granule cells. 13, 48 Importantly, lithium pretreatment completely blocked thapsigargin-induced loss of Bcl-2.
Bcl-2 and GRP78 are also induced by another mood stabilizer, VPA, 49, 50 and increasing evidence supports the notion that VPA, like lithium, has neuroprotective effects. We thus examined whether VPA also protects against thapsigargin-induced cytotoxicity of PC12 cells. Pretreatment of cells with 1 mM VPA for 7 days was found to suppress robustly cell death induced by thapsigargin over a wide concentration (100 to 1000 nM) range (Figure 7a ). The cytoprotective effects of VPA were concentration-dependent with a significant protection at a subtherapeutic concentration of 0.1 mM and maximal protection at 1 mM (Figure 7b ). Higher concentrations of VPA produced no protection at 2 mM, but in contrast, potentiated cytotoxicity at 3 and 5 mM.
DISCUSSION
The present study showed that lithium pretreatment timeand dose-dependently protected PC12 cells from thapsigargin-induced cytotoxicity. The lithium-induced cytoprotection was associated with inhibition of thapsigargin-induced increase in intracellular calcium (Figure 2) . The ER calcium level is maintained through a balance of continuous Ca 2 þ uptake into the ER by a Ca 2 þ -ATPase in the ER membrane on the one hand, and the Ca 2 þ release from the ER via inositol 1,4,5-trisphosphate (IP 3 ) or ryanodine receptors on the other. Thapsigargin, through inhibition of the ER Ca 2 þ -ATPase, prevents Ca 2 þ uptake into the ER and hence leads to ER Ca 2 þ depletion. 38 Previous studies have shown that thapsigargin-induced PC12 cell death involves apoptosis. 51 Both the increase in cytoplasmic Ca 2 þ and the depletion of ER Ca 2 þ induced by thapsigargin can contribute to apoptosis. The role of excessive Ca 2 þ depletion from the ER in thapsigargin cytotoxicity is supported by the observation that blocking ryanodine receptors with dantrolene suppresses cell apoptosis induced by thapsigargin. 52 Since inhibition of thapsigargin-induced Ca 2 þ loss from the ER would prevent both elevation of cytoplasmic Ca 2 þ and depletion of ER Ca 2 þ , treatments that inhibit ER Ca Figure 6 Lithium treatment increases Bcl-2 protein levels and blocks the Bcl-2 proteins loss induced by thapsigargin in PC12 cells. Cells were teated with 2 mM LiCl for 7 days, before being exposed to 100 nM thapsigargin for 12 h. Cells in control experiments received no treatment. Cells were then lysed and aliquots of 100 lg protein were used for Western blotting of Bcl-2 protein. The blot on the top is representative of three independent experiments. Quantified results are means7SEM of three independent experiments. *Po0.05, **Po0.01 compared to control, ww Po0.01 compared to thapsigargin alone. GRP78 is a molecular chaperone that binds Ca 2 þ and protects cells from the deleterious effects of misfolded proteins in the ER. 53 Lithium treatment may reduce the calcium lost from the ER following thapsigargin treatment by reducing the rate of Ca 2 þ efflux from the ER by increasing GRP78 expression. Furthermore, GRP78 suppresses oxyradical accumulation and stabilizes mitochondrial function, as shown by investigations where treatment with a GRP78 antisense oligodeoxynucleotide resulted in increased levels of reactive oxygen species and intracellular calcium following exposure to glutamate and oxidative insults. 40 In addition, GRP78 antisense oligodeoxynucleotide treatment enhanced apoptosis. 54 GRP78 inhibits cytochrome c-mediated caspase activation and forms a complex with caspase-7 and -12, and prevents release of caspase-12 from the ER. 55 These findings suggest that GRP78 plays a critical role in maintaining cell viability against ER-stressinduced cell death. In support of this view, our preliminary data showed that transfection of GRP78 antisense oligonucleotide in PC12 cells substantially reduced lithium cytoprotection against thapsigargin-induced cell death. Interestingly, lithium was reported to inhibit b-amyloid peptide-induced stress in the ER of rabbit hippocampus, but not to prevent oxidative damage and tau phosphorylation. 56 It has been suggested that c-Fos is involved in the induction of GRP78 by thapsigargin and the c-Fos-dependent induction is likely triggered by thapsigargin-induced release of Ca 2 þ from the ER. 42 Lithium-induced GRP78 expression is also preceded by a transient increase in c-Fos mRNA and protein levels (Figure 4) , suggesting a c-Fosdependent mechanism. However, distinct mechanisms are likely involved in triggering c-Fos and GRP78 induction because lithium by itself did not affect basal Ca 2 þ levels (Figure 2 ), suggesting that lithium induces GRP78 without stress on the ER to release its calcium. The inability to show additive effects on GRP78 levels in cells treated with both lithium and thapsigargin may reflect suppression of thapsigargin-induced GRP78 expression due to inhibition of the ER stress-induced Ca 2 þ increase by lithium. c-Fos is known to associate with c-Jun to form a heterodimeric AP-1 transcription factor complex that regulates the expression of a large number of genes. Since recognizable AP-1 interacting sequence motifs are not found in the GRP78 promoter, 42 it seems possible that AP-1 is involved in the regulation of the expression of other protein molecule(s) that are translocated to the nucleus to effect GRP induction. Lithium is known to induce c-Fos protein and AP-1 binding activity. 57, 58 The AP-1 activation by lithium could be the result of inhibition of GSK-3 33 and/or activation of JNK. 58, 59 The observation that inhibition of GSK-3b suppresses ERstress-induced caspase-3 activation is consistent with the former possibility. 37 AP-1 activation may initiate a variety of cellular and physiological responses that can be either antiapoptotic or proapoptotic, depending on the nature of AP-1 binding components and the target genes induced. 60 The result that curcumin blocked lithium's protective effects ( Figure 5 ) suggests that AP-1-mediated gene expression is critically involved in protecting PC12 cells from ER stress.
Long-term lithium treatment not only upregulated Bcl-2 by itself but also prevented thapsigargin-induced downregulation of Bcl-2 ( Figure 6 ), a major antiapoptotic protein on membranes of the ER, mitochondria and nucleus. One of the mechanisms of the cytoprotective effects of Bcl-2 is thought to stem from its ability to inhibit ER calcium depletion. 46, 47 It has been suggested that Bcl-2 may increase the activity of Ca 2 þ -ATPase on the ER membrane, thus directly antagonizing the pharmacological effect of thapsigargin. 47 In addition, Bcl-2 binds to the mitochondrial membrane to stabilize its membrane potential, reduce oxidative stress and suppress cytochrome c release (reviewed in Green and Kroemer 61 ). Gene transfer-mediated Bcl-2 overexpression has been shown to protect against thapsigargin-induced apoptosis. 51 Thus, the loss of Bcl-2 may contribute to thapsigargin-induced cell death, and the upregulation of Bcl-2 may also be involved in the inhibitory effects of lithium on thapsigargin-induced intracellular Ca 2 þ elevation and cytotoxicity. Similar to lithium, long-term VPA pretreatment attenuated thapsigargin-induced PC12 cell death in a concentration-dependent manner (Figure 7) . The cytoprotective effects occurred at the therapeutic and subtherapeutic dose range of this drug. Previous reports have demonstrated that protracted VPA treatment induces GRP78 as well as related proteins, GRP94 and calreticulin, in rat brain and C6 glioma cells. 50, 62, 63 Moreover, Bcl-2 is one of the common proteins induced by VPA and lithium following chronic treatment. 49 In addition, AP-1 transcription factor DNA binding activity is also increased by VPA treatment. 64 Thus, it is conceivable that VPA and lithium protect against thapsigargin cytotoxicity by similar mechanisms. Lithium and VPA are two primary drugs used to treat bipolar mood disorder. Brain imaging and post-mortem studies have revealed a deficit in the volume and number of glia and neurons in discrete brain regions such as the frontal cortex of bipolar patients (reviewed in Gould et al 65 ) . Intriguingly, the loss in volume of the subgenual prefrontal cortex, a region involved in cognitive-emotion control, is much reduced in patients receiving chronic treatment with lithium or VPA. 66 Although detailed longitudinal studies are necessary, these observations do raise the possibility that the neuroprotective actions of mood stabilizers contribute to their therapeutic efficacy in treating mood disorders.
MATERIALS AND METHODS

Materials
Thapsigargin was purchased from Research Biochemical International (RBI, Natick, MA, USA). RPMI 1640 medium, horse serum, fetal calf serum and gentamycin were products Cell Culture of PC12 Cells Undifferentiated rat PC12 pheochromocytoma cells were maintained in RPMI 1640 medium enriched with 10% horse serum, 5% fetal calf serum and gentamycin (50 mg/ml). Monolayer cultures 1 Â 10 6 cells/cm 2 were incubated in plastic dishes coated with 3 mg/ml poly-L-ornithine in a 95% air-5% CO 2 humidified atmosphere at 371C. The culture medium was changed every 72 h.
Measurement of Cell Viability
The dehydrogenase activity within healthy mitochondria that reduces MTT was used to determine cell survival in a quantitative colorimetric assay. 16 The tetrazolium ring of MTT is reduced by various dehydrogenase enzymes in cellular organelles and the product precipitates as blue formazan.
67 PC12 cells were incubated with MTT solution (125 mg/ml) added to the growth medium for 1 h at 371C. The medium was then aspirated and the formazan product was dissolved in dimethyl sulfoxide and quantified spectrophotometrically at 540 nm. The results are expressed as a percentage of the untreated control. Cell injury was also quantitatively assessed by measurement of the release of LDH from cells growing in regular serum-containing media. LDH assay was performed using a CytoTox 96 Non-radioactive Cytotoxicity Assay Kit (Promega, Madison, WI, USA). Aliquots of 50 ml of cell supernatant, or cell lysate were used for LDH measurements. The percentage of LDH release was calculated as the portion of LDH from both supernatant and cell lysate. An insignificant amount of LDH was present in the serum-containing media; this value was considered as background and subtracted from the values obtained in the presence of cells.
was measured using Fura-2 fluorescence with a SPEX AR-CM series photometer coupled to a Nikon Diaphot microscope as previously described, with minor modifications.
68 PC12 cells were grown on glass-bottom dishes coated with 0.001% poly-L-lysine in 0.15 M borate buffer, pH 8.4. Cells were loaded with 2.5 mM Fura-2/AM in KrebsRinger buffer (10 mM HEPES, 145 mM NaCl, 5 mM KCl, 0.5 mM NaHPO 4 , 10 mM glucose, 1 mM MgSO 4 Western Blotting PC12 cells grown in dishes were pretreated with 2 mM lithium chloride for 7 days. Thereafter, cells were treated with thapsigargin (100 nM) for 24 h. Control cells received vehicle, but no drug treatment. Cells were then rinsed with Dulbecco's PBS (1 mM KH 2 PO 4 , 154 mM NaCl, 3 mM Na 2 HPO 4 ), scraped from the dishes and lysed with buffer containing 10 mM Tris-HCl pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 mM EGTA, 0.2 mM sodium orthovanadate, 0.2 mM phenylmethylsulfonyl fluoride (PMSF), 0.5% Nonidet P-40, 5 mg/ml leupetin and 5 mg/ml aprotinin, followed by sonication for 30 s at 50 Hz. Aliquots of 100 mg protein were applied to each lane of a sodium dodecyl sulfate-polyacrylamide gel (SDS-PAGE), electrophoresed using standard methods and transferred electrophoretically onto a PVDF membrane at 25 V for 2 h. Blots were blocked by incubation for 1 h with 5% nonfat milk in PBS with 0.1% Tween 20 and then incubated with a primary antibody of GRP78 polyclonal antibody, Bcl-2 monoclonal antibody or c-Fos monoclonal antibody, for 1 h at room temperature. Blots were then incubated with horseradish peroxidaseconjugated secondary antibody. Detection was made by the enhanced chemiluminescence method using ECL Western blotting reagents. Densitometry was performed by capturing images of the films using a CCD camera (Sierra Scientific, Sunnyvale, CA, USA) and analyzing the band densities using NIH Image 1.6 software. The average optical density of each band was determined and expressed as a percentage of control.
RT-PCR for c-Fos mRNA Total RNA was extracted from PC12 cells using TRI reagentt (Sigma, St Louis, MO, USA) and stored at À801C until used. Total RNA was reverse transcribed by using an RNA PCR kit according to the manufacturer's instructions. For conversion of total RNA to cDNA, a 20 ml reaction mixture was prepared containing 5 U reverse transcriptase AMV (Takara, Kyoto,carried out at 551C for 60 min. Reverse transcription (RT) was terminated by heating to 991C for 5 min followed by rapid chilling on ice. Oligo-nucleotide primers toward c-Fos and b-actin were synthesized as follows. Primers for c-Fos were 5 0 -CTG TCC GTC TCT AGT GCC AA-3 0 and 5 0 -ACT TGG CTG CAG CCA TCT TA-3 0 and primers for b-actin were 5 0 -TGG AGA AGA GCT ATG AGC TGC CTG-3 0 and 5 0 -CAC CAA TCC ACA CAG AGT ACT TG-3 0 . A single cDNA produced from total RNA was amplified by PCR with primers for c-Fos and b-actin. For PCR amplification of cDNA, an aliquot of 100 ml of reaction mixture was prepared containing 1 Â polymerase reaction buffer (10 mM Tris-HCl, pH 8.3 À50 mM KCl), 1.5 mM MgCl 2 , 1 U ampliTaq DNA polymerase (Takara), 0.5 or 1 mg cDNA, and 200 nM of the upstreamand downstream-specific primers. The PCR reaction was carried out for 30 cycles. Aliquots (10 ml) of amplified cDNA products were separated by electrophoresis using 2.0% agarose gels. Gels were stained with ethidium bromide and visualized under UV light. Densitometry was performed by capturing images of the films using a CCD camera (Sierra Scientific, Sunnyvale, CA, USA) and analyzing the band densities using NIH Image 1.6 software. The c-Fos to b-actin ratio was calculated from the density from these bands.
Electrophoretic Mobility Shift Assay of AP-1 Binding AP-1 binding assay was performed as described previously. 59 Briefly, PC12 cells were washed with ice-cold PBS, and then harvested and homogenized on ice in buffer I containing 0.5 M sucrose, 10 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 10 mM KCl, 10% glycerol, 1 mM EDTA, 1 mM dithiothreitol (DTT), 1 mM PMSF, 2 mg/ml each of pepstatin, aprotinin and leupeptin. The homogenate was incubated at 41C for 10 min and the nuclear fraction was then collected by centrifugation at 4000 g for 5 min. The nuclear pellet was resuspended by gentle vortexing in buffer II containing 20 mM HEPES (pH 7.9), 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.3 M NaCl, 0.5 mM DTT, 20% glycerol, 0.5 mM PMSF, and the suspension was kept on ice for 30 min. The nuclear extracts were collected from the supernatant after centrifugation at 12 000 g for 30 min at 41C. Double-stranded DNA oligonucleotides containing consensus sequences for AP-1 (Promega, Madison, WI, USA) were labeled with [g-32 P]ATP by T4 polynucleotide kinase. Nuclear extracts containing 8 mg protein were incubated with labeled oligonucleotides for 20 min at room temperature. Samples were electrophoresed on a nondenaturing 4% polyacrylamide gel. The gel was then vacuum-dried and exposed to X-ray film overnight.
Other Methods
The protein concentrations of samples were determined by the bicinchoninic acid (BCA) method (Pierece, New York, NY, USA), using bovine serum albumin as the standard. Statistical analysis was performed with one-way ANOVA and Student's t-test. Quantified data are expressed as means7SEM from at least three independent experiments.
